Clinical Trial Update: Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating quality of life in locally advanced or metastatic pancreatic cancer treated with gemcitabine and nab-paclitaxel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-10-24